Property	Value
Status
Version
Ad File
Disable Ads Flag
Environment
Moat Init
Moat Ready
Contextual Ready
Contextual URL
Contextual Initial Segments
Contextual Used Segments
AdUnit
SubAdUnit
Custom Targeting
Ad Events
Invalid Ad Sizes

Jane M. Grant-Kels MD, FAAD Advisory Board

Ashish C. Bhatia MD, FAAD Associate Editor

See All Experts

featured

Published in Dermatology

Journal Scan / Research · July 02, 2015

Secukinumab Superior to Ustekinumab for Moderate to Severe Plaque Psoriasis

Journal of the American Academy of Dermatology

Save Recommend

Sign in to PracticeUpdate

Only registered members have full access to PracticeUpdate content.

Not a member?

Join for free

Disclosure statements are available on the authors' profiles:

Robert Brodell MD, FAAD

Journal of the American Academy of Dermatology

Secukinumab Is Superior to Ustekinumab in Clearing Skin of Subjects With Moderate to Severe Plaque Psoriasis: CLEAR, a Randomized Controlled Trial

J Am Acad Dermatol 2015 Jun 16;[EPub Ahead of Print], D Thaçi, A Blauvelt, K Reich, TF Tsai, F Vanaclocha, K Kingo, M Ziv, A Pinter, S Hugot, R You, M Milutinovic

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Secukinumab Superior to Ustekinumab for Moderate to Severe Plaque Psoriasis

Additional Info

Secukinumab Is Superior to Ustekinumab in Clearing Skin of Subjects With Moderate to Severe Plaque Psoriasis: CLEAR, a Randomized Controlled Trial

Further Reading

Efficacy of a Novel Four-Step Skin Care Regimen in Improving Uneven Skin Tone

Outcomes of Treatment With CO2 Laser vs Surgical Deroofing in Patients With Hidradenitis Suppurativa Tunnels

Effectiveness of Treatment With Deucravacitinib in Patients With Plaque, Generalized Pustular, or Erythrodermic Psoriasis

Factors Associated With Maintenance of Clinical Response After Reducing the Dosing Frequency of Tralokinumab in Patients With Moderate to Severe Atopic Dermatitis

Long-Term Efficacy and Safety of Secukinumab in Patients With Moderate to Severe Hidradenitis Suppurativa

Association Between Metformin Use and the Risk of Non-Melanoma Skin Cancer

Allergic Contact Dermatitis Owing to Personal Care Product Use Among Men

Provider-Related Factors Associated With an Increased Likelihood of Performing Benign Skin Biopsies

Effects of Comorbidities on Wound Healing in Patients With Pyoderma Gangrenosum

Non-Steroidal Treatment Approaches for the Management of Patients With Atopic Dermatitis

Prevention of Occupational Contact Dermatitis Among Firefighters

Recently Updated